Tables turned as patients appraise NICE (UK National Institute for Clinical Excellence):
This article was originally published in Clinica
Executive Summary
The UK Consumers' Association is to conduct a "public inquiry-style hearing" into the role and activities of the National Institute for Clinical Excellence (NICE), ahead of the latter's first fundamental government review since it was set up in early 1999. The Association aims to ensure that the patient perspective is represented. Key issues to be discussed at the July 25 meeting will be the involvement of patient organisations in NICE appraisals and the overall adequacy and transparency of the process. The healthcare industry is set to follow developments closely, amid concerns that the government's review may lack independence and thoroughness. The Association of British Health-Care Industries, however, has expressed its support for the government's review plans (see Clinica No 959, p 8).
You may also be interested in...
Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout
Dalzanemdor (SAGE-718) showed no difference from placebo in a Phase II Parkinson’s disease study, raising concerns about readouts later this year in Huntington’s and Alzheimer’s diseases.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.